COVID-19 recoveries in Africa cross one million mark
London, Sep. 4, 2020 (AltAfrica)-The fight against the COVID-19 pandemic in Africa is yielding positive result as over one million persons have recovered from the disease in the continent.
Out of the 1,260,400 persons that have contracted the disease, according to the Africa Centre for Disease Control (Africa CDC), 1,001,581 have recovered.
A further peep into the data from the Africa CDC shows that 30,065 have, however, died due to complications from the pandemic.
Over 1.2 million confirmed #COVID19 cases on the African continent – with more than 1 million recoveries & 30,000 deaths cumulatively.— WHO African Region (@WHOAFRO) September 3, 2020
View country figures & more with the WHO African Region COVID-19 Dashboard: https://t.co/V0fkK8dYTg pic.twitter.com/AEQo08ll0q
Five countries, the Africa Union (AU) agency said, contribute to 70 per cent of the COVID-19 cases on the continent. They are South Africa, Egypt, Morocco, Nigeria and Ethiopia.
South Africa with over 630,000 confirmed cases account for half of Africa’s infections from the pandemic, the agency said.
As at Thursday evening, Egypt nears 100,000 coronavirus cases as daily tolls increase
The country reported 145 new coronavirus cases on Thursday, bringing the total case tally to 99,425 since the outbreak began in February.
Egypt has the second-highest number of infections on the continent so far with 5,440 deaths from the disease.
With over 54,000 cases, Nigeria has the third highest infections from COVID-19 and 1,027 deaths also confirmed, the Africa CDC said.
Meanwhile, the World Health Organization, WHO, wants to secure an initial 230 million doses of any COVID-19 vaccine for Africa, officials said Thursday, while emphasising that any vaccine in development should also be tested on the continent.
The global vaccine allocation plan, called COVAX, aims to help buy and fairly distribute deliver 2 billion doses of approved vaccines by the end of 2021.
“This … (initial batch) will cover 20% of the African population, initially prioritising those who are the front line, health care workers, then expanding to cover vulnerable groups,” Richard Mihigo, the programme area manager for WHO Africa, told an online news conference.
The scheme has nine COVID-19 vaccine candidates covering a range of technologies and scientific approaches. Some are in late-stage clinical trials and could have data available by year-end.
Only two of the potential COVID-19 vaccines are being tested in Africa, said Richard Hatchett, chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI), which co-leads the COVAX project with the WHO and the Gavi vaccines alliance.
“Testing vaccines on the continent ensures that sufficient data is generated on the safety and efficacy of the most promising vaccine candidates for the African population so they can be confidently rolled out in Africa,” he said.
John Nkengasong, the head of the Africa Centres for Disease Control and Prevention, told an online news conference that talks with COVAX would supplement other negotiations with nations such as China, Canada and the United States over securing access to shots.
The continent has fared better than expected, health experts say. The number of new cases fell 11% in the past four weeks, Nkengasong said.
“We are seeing an epidemiological curve that is either stabilising or decreasing, representing a sign of hope,” he said, adding that inadequate testing still means the picture is incomplete